squamous cell carcinoma of the oral cavity

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • +3 more
  • Eliminating RT to the elective neck
  • RT standard of care
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen, Strahlenklinik
Sep 8, 2023

Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Circulating tumor DNA detection
  • Rouen, France
  • +1 more
Jun 29, 2023

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B)

Active, not recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Antitumor B
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jan 18, 2023

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Larynx Trial (Hypofractionated

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Hypofractionated Postoperative Radiotherapy
  • (no location specified)
Sep 12, 2022

Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Soft Palate Trial in Worldwide (biological, drug,

Completed
  • Squamous Cell Carcinoma of the Oral Cavity
  • Squamous Cell Carcinoma of the Soft Palate
  • LI
  • +6 more
  • Springfield, Illinois
  • +101 more
Aug 17, 2022

Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)

Withdrawn
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • (no location specified)
Aug 1, 2022

Squamous Cell Carcinoma of the Oral Cavity Trial in Milwaukee (Antitumor B KAC)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Antitumor B KAC
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jul 6, 2022

Squamous Cell Carcinoma of the Oral Cavity Trial in Edmonton (Resource® Support Plus)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Resource® Support Plus
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
May 13, 2022

Squamous Cell Carcinoma of the Head and Neck, Oral Cancer, Squamous Cell Carcinoma of the Oral Cavity Trial in Rotterdam

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +2 more
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus University Medical Center
Mar 23, 2022

Squamous Cell Carcinoma of the Oral Cavity Trial in Worldwide (GL-0817, Hiltonol, Sargramostim)

Completed
  • Squamous Cell Carcinoma of the Oral Cavity
  • Baltimore, Maryland
  • +32 more
Mar 4, 2022

Squamous Cell Carcinoma, Head And Neck, Squamous Cell Carcinoma Mouth, Squamous Cell Carcinoma of the Oral Cavity Trial in

Completed
  • Squamous Cell Carcinoma, Head And Neck
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Mar 30, 2021

Squamous Cell Carcinoma of the Oral Cavity Trial in Bebington (Nivolumab, Surgery, Radiotherapy, Nivolumab, Surgery,

Active, not recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Nivolumab, Surgery, Radiotherapy
  • Nivolumab, Surgery, Chemoradiotherapy
  • Bebington, United Kingdom
    Clatterbridge Cancer Centre NHS Foundation Trust
Jan 4, 2021

Squamous Cell Carcinoma of the Oral Cavity Trial in Worldwide (biological, drug, dietary supplement)

Unknown status
  • Squamous Cell Carcinoma of the Oral Cavity
  • IRX-2
  • +4 more
  • Tucson, Arizona
  • +21 more
Aug 11, 2020

Squamous Cell Carcinoma of the Oral Cavity Trial in Taipei (ß-glucan)

Unknown status
  • Squamous Cell Carcinoma of the Oral Cavity
  • β-glucan
  • Taipei, Taiwan
    National Taiwan University Hospital
May 10, 2020

Squamous Cell Carcinoma of the Oral Cavity Trial (surgical excision)

Unknown status
  • Squamous Cell Carcinoma of the Oral Cavity
  • surgical excision
  • (no location specified)
Nov 30, 2017

Squamous Cell Carcinoma of the Oral Cavity Trial in Berlin, L'Hospitalet de Llobregat Barcelona, Madrid (drug, procedure,

Terminated
  • Squamous Cell Carcinoma of the Oral Cavity
  • Berlin, Germany
  • +2 more
Jan 2, 2017

Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Oropharynx Trial in United States (GC4419)

Completed
  • Squamous Cell Carcinoma of the Oral Cavity
  • Squamous Cell Carcinoma of the Oropharynx
  • Lakeland, Florida
  • +9 more
Sep 21, 2016

Oropharynx Cancer, Squamous Cell Carcinoma of the Oral Cavity Trial in Germany (Taxotere, Cisplatin, 5-Fluorouracil (5-FU))

Completed
  • Oropharynx Cancer
  • Squamous Cell Carcinoma of the Oral Cavity
  • Taxotere, Cisplatin, 5-Fluorouracil (5-FU)
  • Bielefeld, Germany
  • +3 more
May 17, 2016

Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium

Completed
  • Squamous Cell Carcinoma of the Oral Cavity
  • +3 more
    • New York, New York
      Mount Sinai School of Medicine
    Jun 20, 2012

    F-18-FDG-PET and Optical Imaging in Evaluation of

    Terminated
    • Squamous Cell Carcinoma of the Oral Cavity
    • +2 more
    • endoscopic examination
    • FDG-PET
    • Ghent, Belgium
      University Hospital Ghent
    May 25, 2011